Jack Kaye

Entity
Individual
Business address
C/O Keryx Biopharmaceuticals, 750 Lexington Avenue, 10022 New York, US
Signature Ownership
/s/ Christian Klemt, Attorney-in-Fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Jack Kaye has filed 50 SEC EDGAR filings since 9/22/2006

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT Jun 24, 2025 Jun 20, 2025 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT Jun 13, 2025 Jun 11, 2025 001-36294
4 Open Document Open Filing FORM 4 Mar 7, 2025 Mar 5, 2025 001-32513
4 Open Document Open Filing FORM 4 Jan 7, 2025 Jan 2, 2025 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT Jun 21, 2024 Jun 19, 2024 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT Jun 17, 2024 Jun 13, 2024 001-36294
5 Open Document Open Filing Feb 6, 2024 Dec 31, 2023 001-36294
4 Open Document Open Filing FORM 4 Jan 4, 2024 Jan 2, 2024 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT Jun 20, 2023 Jun 13, 2023 001-36294
4 Open Document Open Filing FORM 4 SUBMISSION Mar 1, 2023 Feb 27, 2023 001-36294
5 Open Document Open Filing FORM 5 Jan 5, 2023 Dec 31, 2022 001-32513
4 Open Document Open Filing FORM 4 Jan 5, 2023 Jan 3, 2023 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT Jun 17, 2022 Jun 15, 2022 001-36294
4 Open Document Open Filing FORM 4 Jun 14, 2022 Jun 10, 2022 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT Mar 2, 2022 Feb 28, 2022 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT Feb 28, 2022 Feb 24, 2022 001-36294
4 Open Document Open Filing FORM 4 Jan 5, 2022 Jan 3, 2022 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT Mar 4, 2021 Mar 2, 2021 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT Mar 1, 2021 Feb 25, 2021 001-36294
4 Open Document Open Filing FORM 4 Jan 6, 2021 Jan 4, 2021 001-32513
4 Open Document Open Filing PRIMARY DOCUMENT Mar 2, 2020 Feb 27, 2020 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT Jan 30, 2020 Jan 28, 2020 001-36294
4 Open Document Open Filing FORM 4 Jan 3, 2020 Jan 2, 2020 001-32513
4 Open Document Open Filing FORM 4 Jun 27, 2019 Jun 25, 2019 001-32513
3 Open Document Open Filing FORM 3 Feb 13, 2019 Feb 12, 2019 000-55264
4 Open Document Open Filing PRIMARY DOCUMENT Jan 31, 2019 Jan 28, 2019 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT Jan 31, 2019 Jan 25, 2019 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT Jan 31, 2018 Jan 29, 2018 001-36294
4 Open Document Open Filing PRIMARY DOCUMENT Jan 30, 2018 Jan 26, 2018 001-36294
4 Open Document Open Filing FORM 4 Jan 31, 2017 Jan 27, 2017 001-36294
3 Open Document Open Filing FORM 3 Jan 10, 2017 Jan 1, 2017 001-36294
4 Open Document Open Filing FORM 4 SUBMISSION Jun 18, 2015 Jun 17, 2015 000-30929
4 Open Document Open Filing FORM 4 SUBMISSION Jun 26, 2014 Jun 24, 2014 000-30929